The major predictors of testing positive for COVID-19 among symptomatic hospitalized patients
Preprint
- 13 September 2020
- preprint
- other
- Published by Cold Spring Harbor Laboratory
Abstract
Introduction Increasing corona virus disease 2019 (COVID-19) pre-test probability can minimize testing patients who are less likely to have COVID-19 and therefore reducing personal protective equipment and COVID-19 testing kit use. The aim of this study was to identify patients who were likely to test positive for COVID-19 among symptomatic patients suspected of having COVID-19 during hospitalization by comparing COVID-19 positive and negative patients. Method We conducted a retrospective chart review of patients who were ≥18 years old and underwent COVID-19 Polymerase chain reaction test because they presented with symptoms thought to be due to COVID-19. The Poisson regression analysis was conducted after clinical presentation, demographic, medical co-morbidities, laboratory and chest image data was retrieved from the medical records. Results Charts of 277 and 35 COVID-19 negative and positive patients respectively were analyzed. Dyspnea (61%) was the most common symptom among COVID-19 negative patients, while 83% and 77% COVID-19 positive patients had cough and fever respectively. COVID-19 positive patients were more likely to present initially with cough [1.082 (1.022 - 1.145)] and fever [1.066 (1.013 - 1.122)], besides being males [1.066 (1.013 - 1.123)] and 50 to 69 years old [1.090 (1.019 - 1.166)]. Dyspnea, weakness, lymphopenia and bilateral chest image abnormality were not associated with COVID-19 positivity. COVID-19 positive patients were less likely to have non-COVID-19 respiratory viral illness [0.934 (0.893 - 0.976)], human immunodeficiency virus [0.847 (0.763 - 0.942)] and heart failure history [0.945 (0.908 - 0.984)]. Other chronic medical problems (hypertension, diabetes mellitus, chronic obstructive pulmonary disease and coronary artery disease) were not associated with testing positive for COVID-19. Conclusion Cough and fever are better predictors of symptomatic COVID-19 positivity during hospitalization. Despite published studies reporting a high prevalence of lymphopenia among COVID-19 positive patients, lymphopenia is not associated with the risk of testing positive for COVID-19.Keywords
This publication has 9 references indexed in Scilit:
- Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19PLOS ONE, 2020
- Clinical Characteristics of Covid-19 in New York CityThe New England Journal of Medicine, 2020
- Individualizing Risk Prediction for Positive Coronavirus Disease 2019 TestingSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2020
- Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysisJournal of Intensive Care, 2020
- Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, WashingtonClinical Infectious Diseases, 2020
- The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, ChinaJournal of Medical Virology, 2020
- Heart Failure: Diagnosis, Management and UtilizationJournal of Clinical Medicine, 2016
- Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implicationsTherapeutic Advances in Chronic Disease, 2014
- Influenza: incidence, symptoms and treatmentBritish Journal of Nursing, 2005